Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 9, 2000, Pages 3338-3342

  Bastard, Jean Philippe ^a,b,c   Jardel, Claude ^a   Bruckert, Eric ^d   Blondy, Patricia ^a   Capeau, Jacqueline ^b,c   Laville, Martine ^c   Vidal, Hubert ^c   Hainque, Bernard ^a,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL TENON   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; WEIGHT REDUCTION;

EID: 0033678516     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.9.3338     Document Type: Article

References (37)

1. Adipose tissue as an endocrine and paracrine organ
2. Leptin: The tale of an obesity gene
3. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
4. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo
5. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
6. Chronic leptin administration increases insulin-stimulated skeletal muscle glucose uptake and transport
7. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
8. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness
9. Tumor necrosis factor α: A key component of the obesity-diabetes link
10. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
11. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
12. TNF-α and insulin resistance: Summary and future prospects
13. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycaemic control in patients with NIDDM
14. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity
15. Circulating TNF-α and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity
16. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
18. Defective regulation of phosphatidyl-inositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients
19. Peroxisome proliferator activated receptor-γ, leptin and tumor necrosis factor-α mRNA expression during very low calorie diet in sc adipose tissue in obese women
20. Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies
21. A simple index of insulin resistance
22. C-reactive protein in healthy Subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?
23. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
24. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia
25. Omental and subcutaneous adipose tissues of obese subjects release interleukin 6: Depot difference and regulation by glucocorticoid
26. The differential effect of food intake and β-adrenergic stimulation on adipose-derived hormones and cytokines in man
27. Circulating interleukin 6 concentrations and insulin resistance in patients with cancer
28. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
29. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
30. Endocrinologic and metabolic effects of interleukin-6 in humans
31. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vitro and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia
32. Interleukin 1 beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes
33. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation
34. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
35. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
36. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss
37. Plasma concentrations of soluble TNF-α receptors in obese subjects